$MBOT News

LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System

Microbot Medical Inc. (MBOT) Shareholder/Analyst Call Transcript

Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report On Co

Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As Global Expansion Accelerates

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

Microbot Medical Completes Limited Market Release Of Its LIBERTY Endovascular Robotic System, With Commencement Of Full Market Release In The U.S. Proceeding As Planned

Microbot Medical Entered ATM Agreement With H.C. Wainwright & Co; May Offer & Sell Up To $39.2M

Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System

Emory Healthcare Announces Successful Use Of Microbot Medical's Liberty System In Robotic Peripheral Endovascular Procedures

Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

Microbot Medical Announces Publication Of Peer-Reviewed Data On Liberty Access Study In The Journal of Vascular and Interventional Radiology

Microbot Medical Announces Publication Of Peer-Reviewed Data On Liberty Access Study In The Journal of Vascular and Interventional Radiology

Microbot Medical® to Participate at the 38th Annual Roth Conference

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation